These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7512199)

  • 21. [Use of micronucleus tests for screening mutagens and carcinogens].
    Sycheva LP; Zhukov VS
    Vestn Ross Akad Med Nauk; 1997; (7):14-8. PubMed ID: 9324374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenic and carcinogenic actions of chromium and its compounds.
    Mamyrbaev AA; Dzharkenov TA; Imangazina ZA; Satybaldieva UA
    Environ Health Prev Med; 2015 May; 20(3):159-67. PubMed ID: 25877777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The hygienic evaluation of the mutagenic potential of industrial wastes].
    Zhurkov VS; Rusakov NV; Tonkopiĭ NI; Sycheva LP; Akhal'tseva LV; Neiaskina EV; Pirtakhiia NV; Malysheva AG; Rastiannikov EG
    Gig Sanit; 1998; (4):30-2. PubMed ID: 9721500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenic and carcinogenic constituents of medicinal herbs used in Europe or in the USA.
    Bertram B; Hemm I; Tang W
    Pharmazie; 2001 Feb; 56(2):99-120. PubMed ID: 11234357
    [No Abstract]   [Full Text] [Related]  

  • 25. Mutagenic carcinogens and noncarcinogens in transgenic mice.
    Günzel P; Reimann R
    Environ Health Perspect; 1997 Feb; 105(2):163. PubMed ID: 9105788
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutagenicity of nitrobenzyl derivatives: potential bioreductive anticancer agents.
    Juneja TR; Bala A; Kumar P; Gupta RL
    Mutat Res; 1995 Nov; 348(3):137-45. PubMed ID: 8524366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenic impurities in pharmaceuticals: a critique of the derivation of the cancer TTC (Threshold of Toxicological Concern) and recommendations for structural-class-based limits.
    Snodin DJ; McCrossen SD
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):299-316. PubMed ID: 23988886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity, carcinogenicity and teratogenicity of thallium compounds.
    Léonard A; Gerber GB
    Mutat Res; 1997 Aug; 387(1):47-53. PubMed ID: 9254892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens.
    Ashby J; Waters MD; Preston J; Adler ID; Douglas GR; Fielder R; Shelby MD; Anderson D; Sofuni T; Gopalan HN; Becking G; Sonich-Mullin C
    Mutat Res; 1996 Jun; 352(1-2):153-7. PubMed ID: 8676904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-Chloromethylbiphenyl (4CMB): a novel mutagen and potential carcinogen.
    Ashby J; Trueman RW; Styles J; Penman MG; Paton D
    Carcinogenesis; 1981; 2(1):33-8. PubMed ID: 7023721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds.
    Léonard A; Gerber GB
    Mutat Res; 1994 Feb; 317(1):81-8. PubMed ID: 7507574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impurities.
    Galloway SM; Vijayaraj Reddy M; McGettigan K; Gealy R; Bercu J
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):326-35. PubMed ID: 23688841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency.
    White PA; Rasmussen JB
    Environ Mol Mutagen; 1996; 27(4):270-305. PubMed ID: 8665872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paving asphalt products exhibit a lack of carcinogenic and mutagenic activity.
    Goyak KO; McKee RH; Minsavage GD; McGowan C; Daughtrey WC; Freeman JJ
    Int J Toxicol; 2011 Oct; 30(5):492-7. PubMed ID: 21878556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso-N-methylurea.
    Ariazi JL; Haag JD; Lindstrom MJ; Gould MN
    Mol Carcinog; 2005 Jul; 43(3):155-64. PubMed ID: 15924352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragrance material review on benzyl cinnamate.
    Bhatia SP; Wellington GA; Cocchiara J; Lalko J; Letizia CS; Api AM
    Food Chem Toxicol; 2007; 45 Suppl 1():S40-8. PubMed ID: 18037214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity of trialkyltriazenes: mutagenic potency of alkyldiazonium ions, the putative ultimate carcinogens from dialkylnitrosamines.
    Sieh DH; Andrews AW; Michejda CJ
    Mutat Res; 1980 Dec; 73(2):227-35. PubMed ID: 7007875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.